Arrowhead Pharmaceuticals Shares Are On The Rise Today: What's Going On?
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) shares are trading higher Tuesday after the company announced a global ...
STAT1d
Sarepta, Arrowhead Pharmaceuticals partner to advance RNA-based drugs in rare diseases
Sarepta Therapeutics said it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based ...
Arrowhead Pharmaceuticals, Inc. (ARWR) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Conference Call November 26, 2024 4:30 PM ET. Company Participants. Vince Anzalone - VP, IR Chris Anzalone - Preside ...
fandomwire5d
There’s 1 Way Helldivers 2 Can Become Better Than Space Marine 2: It Involves Arrowhead Copying Bungie
Could Helldivers 2 learn something valuable from Bungie's approach to franchise building? The answer might surprise you.
Chiefs seek feedback on renovated Arrowhead, new stadium options. Here’s how (and why)
The Chiefs are in detailed financial conversations regarding sites in Kansas and Missouri, including their current one at the ...
Colorado will be "Iced out" vs. Kansas at Arrowhead Stadium
Colorado is bringing an "iced out" look to Arrowhead Stadium this weekend for their critical Big 12 showdown against Kansas.
Christmas in July: How the Chiefs’ Arrowhead Stadium became the setting of Hallmark’s biggest movie yet
TODAY goes on location for "Holiday Touchdown," a new movie made in partnership with the Kansas City Chiefs and Hallmark.
Top highlights from Kansas Jayhawks' win vs. Colorado Buffaloes at Arrowhead Stadium
The Kansas City Chiefs are in Charleston this weekend taking on the Carolina Panthers, and with the reigning Super Bowl ...
Arrowhead Pharmaceuticals Reports 2024 Fiscal Year-End Results
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced financial results for its 2024 fiscal year ended September 30, 2024. The Company is hosting a conference ...
FierceBiotech1d
Sarepta pays $500M cash for rights to 'multiple potential blockbusters' from Arrowhead
Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for ...